The importance of TCF4 gene in the etiology of recurrent depressive disorders

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 80, Issue , 2018, Pages 304-308

  Mossakowska Wójcik, Joanna ^a   Orzechowska, Agata ^a   Talarowska, Monika ^a   Szemraj, Janusz ^a   Gałecki, Piotr ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Depression; Etiology; Expression; TCF4 gene

Indexed keywords

MESSENGER RNA; SEROTONIN UPTAKE INHIBITOR; TCF4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR 4;

AGE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; GENE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; RECURRENT DEPRESSIVE DISORDER; RECURRENT DISEASE; SEX; TCF4 GENE; BIOSYNTHESIS; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; SEX FACTOR;

AGE FACTORS; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RECURRENCE; RNA, MESSENGER; SEX FACTORS; TRANSCRIPTION FACTOR 4;

EID: 85016745504     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2017.03.014     Document Type: Article

References (50)

1. Spijker, J., Graaf, R., Bijl, R.V., Beekman, A.T., Ormel, J., Nolen, W.A., Functional disability and depression in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiatr. Scand. 110 (2004), 208–214.
2. Ustun, T.B., Ayuso-Mateos, J.L., Chatterji, S., Mathers, C., Murray, C.J., Global burden of depressive disorders in the year 2000. Br. J. Psychiatry 184 (2004), 386–392.
3. Gałecki, P., Talarowska, M., The evolutionary theory of depression. Med. Sci. Monit., 2017 https://doi.org/10.12659/MSM.901240.
4. Anguelova, M., Benkelfat, C., Turecki, G., A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders. Mol. Psychiatry 8 (2003), 574–591.
5. Stefansson, H., Ophoff, R.A., Steinberg, S. et al., Genetic Risk and Outcome in Psychosis, (GROUP) common variants conferring risk of schizophrenia. Nature 460:7256 (2009), 744–747.
6. Talarowska, M., Szemraj, J., Gałecki, P., The role of interleukin genes in the course of depression. Open Med. 11 (2016), 41–48, 10.1515/med-2016-0009.
7. Hoyo-Becerra, C., Schlaak, J.F., Hermann, D.M., Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation. Brain Behav. Immun. 42 (2014), 222–231.
8. Henthorn, P., Kiledjian, M., Kadesch, T., Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. Science 247 (1990), 467–470.
9. Corneliussen, B., Thornell, A., Hallberg, B., Grundstrom, T., Helix-Loop-Helix transcriptional activators bind to a sequence in glucocorticoid response elements of retrovirus enhancers. J. Virol. 65 (1991), 6084–6093.
10. Soosaar, A., Chiaramello, A., Zuber, M.X., Neuman, T., Expression of basic-helix-loop-helix transcription factor ME2 during brain development and in the regions of neuronal plasticity in the adult brain. Mol. Brain Res. 25 (1994), 176–180.
11. de Pontual, L., Mathieu, Y., Golzio, C. et al., Mutational, functional, and expression studies of the TCF4 gene in Pitt-Hopkins syndrome. Hum. Mutat. 30 (2009), 669–676.
12. Sepp, M., Kannike, K., Eesmaa, A., Urb, M., Timmusk, T., Functional diversity of human basic helix-loop-helix transcription factor TCF4 isoforms generated by alternative 5′ exon usage and splicing. PLoS One, 6(7), 2011, e22138.
13. Persson, P., Jogi, A., Grynfeld, A., Pahlman, S., Axelson, H., HASH-1 and E2–2 are expressed in human neuroblastoma cells and form a functional complex. Biochem. Biophys. Res. Commun. 274 (2000), 22–31.
14. Flora, A., Garcia, J.J., Thaller, C., Zoghbi, H.Y., The E-protein Tcf4 interacts with Math1 to regulate differentiation of a specific subset of neuronal progenitors. Proc. Natl. Acad. Sci. 104 (2007), 15382–15387.
15. Ravanpay, A.C., Olson, J.M., E protein dosage influences brain development more than family member identity. J. Neurosci. Res. 86 (2008), 1472–1481.
16. Brzózka, M.M., Radyushkin, K., Wichert, S.P., Ehrenreich, H., Rossner, M.J., Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain. Biol. Psychiatry 68 (2010), 33–40.
17. Zweier, C., Sticht, H., Bijlsma, E.K. et al., Further delineation of Pitt-Hopkins syndrome: Phenotypic and genotypic description of 16 novel patients. J. Med. Genet. 45 (2008), 738–744.
18. Marangi, G., Ricciardi, S., Orteschi, D. et al., The Pitt-Hopkins syndrome: report of 16 new patients and clinical diagnostic criteria. Am. J. Med. Genet. 155A (2011), 1536–1545.
19. Whalen, S., Héron, D., Gaillon, T. et al., Novel comprehensive diagnostic strategy in Pitt-Hopkins syndrome: clinical score and further delineation of the TCF4 mutational spectrum. Hum. Mutat. 33 (2012), 64–72.
20. O'Donnell, L., Soileau, B., Heard, P., Carter, E., Sebold, C., Gelfond, J., Hale, D.E., Cody, J.D., Genetic determinants of autism in individuals with deletions of 18q. Hum. Genet. 128 (2010), 155–164.
21. Hasi, M., Soileau, B., Sebold, C. et al., The role of the TCF4 gene in the phenotype of individuals with 18q segmental deletions. Hum. Genet. 130 (2011), 777–787.
22. Berrettini, W.H., Ferraro, T.N., Goldin, L.R. et al., Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene. Proc. Natl. Acad. Sci. 91 (1994), 5918–5921.
23. Stine, O.C., Xu, J., Koskela, R. et al., Evidence for linkage of bipolar disorder to chromsome 18 with a parent-of-origin effect. Am. J. Hum. Genet. 57 (1995), 1384–1394.
24. Freimer, N.B., Reus, V.I., Escamilla, M.A. et al., Genetic mapping using haplotype, association and linkage methods suggests a locus for severe bipolar disorder (BPI) at 18q22–q23. Nat. Genet. 12 (1996), 436–441.
25. Steinberg, S., de Song, S., Andreassen, O.A. et al., Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum. Mol. Genet. 20 (2011), 4076–4081.
26. Ripke, S., Sanders, A.R., Kendler, K.S. et al., Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 43 (2011), 969–976.
27. Williams, H.J., Craddock, N., Russo, G. et al., Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. Hum. Mol. Genet. 20:2 (2011), 387–391.
28. Lennertz, L., Rujescu, D., Wagner, M. et al., Novel schizophrenia risk gene TCF4 influences verbal learning and memory functioning in schizophrenia patients. Neuropsychobiology 63 (2011), 131–136.
29. Quednow, B.B., Ettinger, U., Mössner, R. et al., The schizophrenia risk allele C of the TCF4 rs9960767 polymorphism disrupts sensorimotor gating in schizophrenia spectrum and healthy volunteers. J. Neurosci. 31 (2011), 6684–6691.
30. Mudge, J., Miller, N.A., Khrebtukova, I. et al., Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum. PLoS One, 3, 2008, e3625.
31. Kurian, S.M., Le-Niculescu, H., Patel, S.D. et al., Identification of blood biomarkers for psychosis using convergent functional genomics. Mol. Psychiatry 16 (2009), 37–58.
32. Cisse, B., Caton, M.L., Lehner, M. et al., Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135:1 (2008), 37–48.
33. Esashi, E., Liu, Y.J., E-box protein E2-2 is a crucial regulator of plasmacytoid DC development. Eur. J. Immunol. 38:9 (2008), 2386–2388.
34. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. 1992, World Health Organisation.
35. Patten, S., Performance of the composite international diagnostic interview short form for major depression in community and clinical samples. Chron. Dis. Can. 18:3 (1997), 18–24.
36. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(− Delta Delta C(T)) Method. Methods 25:4 (2001), 402–408.
37. Zhong, L., Cherry, T., Bies, C.E., Florence, M., Gerges, N.Z., Neurogranin enhances synaptic strength through its interaction with calmodulin. EMBO J. 28 (2009), 3027–3039.
38. Airaksinen, E., Wahlin, A., Larsson, M., Forsell, Y., Cognitive and social functioning in recovery from depression: results from a population-based three-year follow-up. J. Affect. Disord. 96 (2006), 107–110.
39. Kessing, L.V., Cognitive impairment in the euthymic phase of affective disorder. Psychol. Med. 28 (1998), 1027–1038.
40. Simons, C.J., Jacobs, N., Derom, C. et al., Cognition as predictor of current and follow-up depressive symptoms in the general population. Acta Psychiatr. Scand. 120 (2009), 45–52.
41. Lander, E., Schork, N., Genetic dissection of complex traits. Science 265 (1994), 2037–2048.
42. Sullivan, P., Neale, M., Kendler, K., Genetic epidemiology of major depression: review and meta-analysis. Am. J. Psychiatry 157:10 (2000), 1552–1562.
43. Maier, W., Lichtermann, D., Minges, J. et al., Continuity and discontinuity of affective disorders and schizophrenia: result of a controlled family study. Arch. Gen. Psychiatry 50 (1993), 871–883.
44. Weissman, M.M., Wickramaratne, P., Adams, P.B. et al., The relationship between panic disorder and major depression: a new family study. Arch. Gen. Psychiatry 50 (1993), 767–780.
45. von Knorring, A.L., Cloninger, C.R., Bohman, M., Sigvardsson, S., An adoption study of depressive disorders and substance abuse. Arch. Gen. Psychiatry 40 (1983), 943–950.
46. Bierut, L.J., Heath, A.C., Bucholz, K.K. et al., Major depressive disorder in a community-based twin sample: are there different genetic and environmental contributions for men and women?. Arch. Gen. Psychiatry 56 (1999), 557–563.
47. Dudley, K.J., Li, X., Kobor, M.S., Kippin, T.E., Bredy, T.W., Epigenetic mechanisms mediating vulnerability and resilience to psychiatric disorders. Neurosci. Biobehav. Rev. 35 (2011), 1544–1551.
48. Caspi, A., Sugden, K., Moffitt, T. et al., Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 (2003), 386–389.
49. Weaver, I.C., Cervoni, N., Champagne, F.A. et al., Epigenetic programming by maternal behavior. Nat. Neurosci. 7 (2004), 847–854.
50. Sullivan, P.F., Fan, C., Perou, C.M., Evaluating the comparability of gene expression in blood and brain. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B (2006), 261–268.